{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-105148","form_type":"8-K","ticker":"ITRMF","cik":"0001659323","company_name":"Iterum Therapeutics plc","filed_at":"2025-04-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.236539+00:00","generated_at":"2026-05-23T02:24:39.870915+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"confidence":"high","headline":"Iterum Therapeutics announces $5M registered direct offering of ordinary shares and pre-funded warrants","bullets":["Gross proceeds of $5.0M from sale of 5,555,556 shares/warrants at $0.90 each.","Net proceeds ~$4.2M after fees; H.C. Wainwright acting as placement agent.","Funding to support pre-commercialization of ORLYNVAH and strategic process, cash runway into 2026.","Offering expected to close April 30, 2025, subject to customary conditions.","Pre-funded warrants exercisable at $0.01 per share with 9.99% beneficial ownership cap."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-105148","json":"https://secwatch.observer/filing/0001193125-25-105148.json","markdown":"https://secwatch.observer/filing/0001193125-25-105148.md","text":"https://secwatch.observer/filing/0001193125-25-105148.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1659323/000119312525105148/0001193125-25-105148-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1659323/000119312525105148/d803323d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T02:24:39.870915+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}